Published in Clin Cancer Res on November 01, 2007
Bayesian method to predict individual SNP genotypes from gene expression data. Nat Genet (2012) 2.50
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis (2010) 2.46
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med (2008) 1.99
Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A (2010) 1.87
Retracted Gene expression profiling analysis of hepatocellular carcinoma. Eur J Med Res (2013) 1.39
A kernel-based integration of genome-wide data for clinical decision support. Genome Med (2009) 1.26
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol (2009) 1.10
Exploring genomic profiles of hepatocellular carcinoma. Mol Carcinog (2011) 1.05
Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig Dis Sci (2008) 1.04
Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects. World J Gastroenterol (2014) 0.93
Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation. PLoS Med (2014) 0.91
Molecular classification of hepatocellular carcinoma: potential therapeutic implications. Hepat Oncol (2015) 0.84
Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. J Cancer Res Clin Oncol (2011) 0.83
HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. J Transl Med (2015) 0.80
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma. BMC Cancer (2016) 0.78
Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression. Int J Clin Exp Pathol (2015) 0.78
Clinicopathologic and gene expression parameters predict liver cancer prognosis. BMC Cancer (2011) 0.78
Molecular characterization of hepatocarcinogenesis using mouse models. Dis Model Mech (2015) 0.78
Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma. Int J Clin Oncol (2012) 0.78
The expression of embryonic liver development genes in hepatitis C induced cirrhosis and hepatocellular carcinoma. Cancers (Basel) (2012) 0.77
Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. Clinics (Sao Paulo) (2016) 0.75
Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition. Int J Cancer (2015) 0.75
Deregulation upon DNA damage revealed by joint analysis of context-specific perturbation data. BMC Bioinformatics (2011) 0.75
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology (2013) 1.87
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut (2011) 1.56
MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One (2012) 1.42
Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells (2013) 1.37
Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells (2009) 1.26
Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts. Br J Haematol (2002) 1.26
Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma (2003) 1.19
Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res (2011) 1.15
Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett (2010) 1.14
Cytokine-induced NK-like T cells: from bench to bedside. J Biomed Biotechnol (2010) 1.13
Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin Cancer Res (2010) 1.09
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med (Berl) (2011) 1.05
Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell. Immunology (2008) 1.03
Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays. Exp Hematol (2005) 0.97
Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer (2011) 0.97
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. Br J Pharmacol (2013) 0.95
Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. J Pharmacol Exp Ther (2010) 0.91
Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med (Maywood) (2009) 0.90
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS One (2012) 0.90
Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma. PLoS One (2013) 0.90
Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor. Int J Cancer (2005) 0.89
Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth. J Hepatol (2013) 0.89
CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma. Hepatology (2015) 0.89
Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer (2002) 0.88
A paper-based microfluidic electrochemical immunodevice integrated with amplification-by-polymerization for the ultrasensitive multiplexed detection of cancer biomarkers. Biosens Bioelectron (2013) 0.88
Cystic neoplasms of the pancreas: current diagnostic modalities and management. Ann Acad Med Singapore (2009) 0.84
A microarray study to characterize the molecular mechanism of TIMP-3-mediated tumor rejection. Mol Ther (2005) 0.84
CIK cells--current status, clinical perspectives and future prospects--the good news. Expert Opin Biol Ther (2012) 0.84
Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation. Int J Cancer (2003) 0.83
Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget (2014) 0.83
Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration. J Virol Methods (2006) 0.82
Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector. Hum Gene Ther (2004) 0.82
Cloning and identification of hepatocellular carcinoma down-regulated mitochondrial carrier protein, a novel liver-specific uncoupling protein. J Biol Chem (2004) 0.82
Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma. Cancer Immunol Immunother (2008) 0.82
Isolation of peptide ligands that interact specifically with human glioma cells. Peptides (2009) 0.81
An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas. Mol Ther (2007) 0.81
Highly specific and ultrasensitive graphene-enhanced electrochemical detection of low-abundance tumor cells using silica nanoparticles coated with antibody-conjugated quantum dots. Anal Chem (2013) 0.81
Clinical and molecular evaluation of warming and tonic herb treatment for sibling patients of a typical kidney-yang deficiency family. Am J Chin Med (2006) 0.80
Transcriptional down-regulation of IGFBP-3 in human hepatocellular carcinoma cells is mediated by the binding of TIA-1 to its AT-rich element in the 3'-untranslated region. Cancer Lett (2010) 0.80
Paper-based microfluidic electrochemical immunodevice integrated with nanobioprobes onto graphene film for ultrasensitive multiplexed detection of cancer biomarkers. Anal Chem (2013) 0.80
Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma. Stem Cells Dev (2013) 0.79
An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins. Apoptosis (2013) 0.79
Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression. J Clin Invest (2016) 0.79
Image-guided radiofrequency ablation of liver malignancies: experience at Singapore General Hospital. Ann Acad Med Singapore (2006) 0.79
Identification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene delivery. Hum Gene Ther (2004) 0.78
Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells. Hum Gene Ther (2007) 0.78
Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors. Hum Gene Ther (2002) 0.78
Induction of potent TRAIL-mediated tumoricidal activity by hFLEX/Furin/TRAIL recombinant DNA construct. Mol Ther (2004) 0.77
Results of resections for hepatocellular carcinoma in a new hepatobiliary unit. ANZ J Surg (2003) 0.76
Comprehensive detection of cancer gene expression profiles and gene networks are impacted by the choice of pre-processing algorithm and gene-selection method. Int J Data Min Bioinform (2013) 0.75